citalopram has been researched along with Fatigue Syndrome, Chronic in 4 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Fatigue Syndrome, Chronic: A syndrome characterized by persistent or recurrent fatigue, diffuse musculoskeletal pain, sleep disturbances, and subjective cognitive impairment of 6 months duration or longer. Symptoms are not caused by ongoing exertion; are not relieved by rest; and result in a substantial reduction of previous levels of occupational, educational, social, or personal activities. Minor alterations of immune, neuroendocrine, and autonomic function may be associated with this syndrome. There is also considerable overlap between this condition and FIBROMYALGIA. (From Semin Neurol 1998;18(2):237-42; Ann Intern Med 1994 Dec 15;121(12): 953-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| "In design 1, fatigue for subjects taking citalopram was significantly and substantially reduced when subjects were switched from placebo to citalopram, p <." | 9.10 | The effectiveness of citalopram for idiopathic chronic fatigue. ( Bentler, SE; Brake, KA; Hartz, AJ; Kelly, MW, 2003) |
| "In design 1, fatigue for subjects taking citalopram was significantly and substantially reduced when subjects were switched from placebo to citalopram, p <." | 5.10 | The effectiveness of citalopram for idiopathic chronic fatigue. ( Bentler, SE; Brake, KA; Hartz, AJ; Kelly, MW, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kumar, A | 1 |
| Garg, R | 1 |
| Weinbacher, BS | 1 |
| Hartz, AJ | 1 |
| Bentler, SE | 1 |
| Brake, KA | 1 |
| Kelly, MW | 1 |
| Amsterdam, JD | 1 |
| Shults, J | 1 |
| Rutherford, N | 1 |
2 trials available for citalopram and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
The effectiveness of citalopram for idiopathic chronic fatigue.
Topics: Adult; Aged; Chronic Disease; Citalopram; Drug Administration Schedule; Fatigue; Fatigue Syndrome, C | 2003 |
Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Drug | 2008 |
2 other studies available for citalopram and Fatigue Syndrome, Chronic
| Article | Year |
|---|---|
Protective effects of antidepressants against chronic fatigue syndrome-induced behavioral changes and biochemical alterations.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Anima | 2009 |
[Persistent fatigue despite sufficient sleep].
Topics: Adult; Age Factors; Antidepressive Agents, Second-Generation; Child; Citalopram; Diagnosis, Differen | 2003 |